PBK/TOPK Expression Predicts Prognosis in Oral Cancer

Int J Mol Sci. 2016 Jun 24;17(7):1007. doi: 10.3390/ijms17071007.

Abstract

Oral cancer is a common cancer with poor prognosis. We evaluated the expression of PBK/TOPK (PDZ-binding kinase/T-LAK cell-originated protein kinase) and its prognostic significance in oral cancer. PBK/TOPK expression was measured by immunohistochemical staining of samples from 287 patients with oral cancer. The association between PBK/TOPK expression and clinicopathological features was analyzed. The prognostic value of PBK/TOPK for overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. A high PBK/TOPK expression level was correlated with long overall survival. The prognostic role of PBK/TOPK expression was significant in young patients (p < 0.05), patients with smoking habits (p < 0.05), and late stage disease (p < 0.05). Our results suggest that PBK/TOPK expression is enhanced in oral cancer. High PBK/TOPK expression, either alone or in subgroups according to clinicopathological features, may serve as a favorable prognostic marker for patients with oral cancer.

Keywords: PBK (PDZ-binding kinase); TOPK (T-LAK cell-originated protein kinase); head and neck cancer; metastasis; oral squamous cell carcinoma; prognosis.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / pathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mitogen-Activated Protein Kinase Kinases / genetics
  • Mitogen-Activated Protein Kinase Kinases / metabolism*
  • Mouth Neoplasms / metabolism*
  • Mouth Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • Mitogen-Activated Protein Kinase Kinases
  • PDZ-binding kinase